Literature DB >> 27550923

Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.

Maria Picken1, Jianrui Long1, Geoffrey A Williamson1, Aaron J Polichnowski2.   

Abstract

The relative contribution of self-perpetuating versus hemodynamic-induced fibrosis to the progression of chronic kidney disease (CKD) after acute kidney injury (AKI) is unclear. In the present study, male Sprague-Dawley rats underwent right uninephrectomy and were instrumented with a blood pressure radiotelemeter. Two weeks later, separate groups of rats were subjected to 40 minutes renal ischemia-reperfusion or sham surgery and followed up for 4 or 16 weeks to determine the extent to which glomerulosclerosis and tubulointerstitial fibrosis as a result of the AKI-CKD transition (ie, at 4 weeks post AKI) change over time during the progression of CKD (ie, at 16 weeks post AKI). On average, tubulointerstitial fibrosis was ≈3-fold lower (P<0.05), whereas glomerulosclerosis was ≈6-fold higher (P<0.05) at 16 versus 4 weeks post AKI. At 16 weeks post AKI, marked tubulointerstitial fibrosis was only observed in rats exhibiting marked glomerulosclerosis, proteinuria, and kidney hypertrophy consistent with a hemodynamic pathogenesis of renal injury. Moreover, quantitative analysis between blood pressure and renal injury revealed a clear and modest blood pressure threshold (average 16-week systolic blood pressure of ≈127 mm Hg) for the development of glomerulosclerosis. In summary, modest levels of blood pressure may be playing a substantial role in the progression of renal disease after AKI in settings of preexisting CKD associated with 50% loss of renal mass. In contrast, these data do not support a major role of self-perpetuating tubulointerstitial fibrosis in the progression CKD after AKI in such settings.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  fibrosis; glomerular filtration rate; glomerulosclerosis, focal segmental; hypertension; ischemia renal circulation

Mesh:

Year:  2016        PMID: 27550923      PMCID: PMC5016243          DOI: 10.1161/HYPERTENSIONAHA.116.07749

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  42 in total

1.  Short- and long-term survival after acute kidney injury.

Authors:  Sean M Bagshaw
Journal:  Nephrol Dial Transplant       Date:  2008-07       Impact factor: 5.992

2.  Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model.

Authors:  Karen A Griffin; Aaron Polichnowski; Natalia Litbarg; Maria Picken; Manjeri A Venkatachalam; Anil K Bidani
Journal:  Hypertension       Date:  2014-06-23       Impact factor: 10.190

Review 3.  Fibrosis--a common pathway to organ injury and failure.

Authors:  Don C Rockey; P Darwin Bell; Joseph A Hill
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

4.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

Authors:  Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates
Journal:  J Am Soc Nephrol       Date:  2005-09-21       Impact factor: 10.121

5.  Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat.

Authors:  J M Forbes; T D Hewitson; G J Becker; C L Jones
Journal:  Kidney Int       Date:  2000-06       Impact factor: 10.612

6.  Contribution of angiotensin II to late renal injury after acute ischemia.

Authors:  Maria Enrica Pagtalunan; Jean L Olson; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2000-07       Impact factor: 10.121

Review 7.  The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function.

Authors:  D P Basile
Journal:  Kidney Int       Date:  2007-05-02       Impact factor: 10.612

Review 8.  Pathophysiology of hypertensive renal damage: implications for therapy.

Authors:  Anil K Bidani; Karen A Griffin
Journal:  Hypertension       Date:  2004-09-27       Impact factor: 10.190

9.  Severe renal mass reduction impairs recovery and promotes fibrosis after AKI.

Authors:  Aaron J Polichnowski; Rongpei Lan; Hui Geng; Karen A Griffin; Manjeri A Venkatachalam; Anil K Bidani
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

10.  Modification of the relationship between blood pressure and renal albumin permeability by impaired excretory function and diabetes.

Authors:  James Fotheringham; Aghogho Odudu; William McKane; Timothy Ellam
Journal:  Hypertension       Date:  2014-12-08       Impact factor: 10.190

View more
  10 in total

1.  Angiotensin (1-7) protects against renal ischemia-reperfusion injury via regulating expression of NRF2 and microRNAs in Fisher 344 rats.

Authors:  Asif Zaman; Anees A Banday
Journal:  Am J Physiol Renal Physiol       Date:  2022-05-09

2.  Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition.

Authors:  Aaron J Polichnowski; Karen A Griffin; Hector Licea-Vargas; Rongpei Lan; Maria M Picken; Jainrui Long; Geoffrey A Williamson; Christian Rosenberger; Susanne Mathia; Manjeri A Venkatachalam; Anil K Bidani
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-16

Review 3.  AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.

Authors:  Liyu He; Qingqing Wei; Jing Liu; Mixuan Yi; Yu Liu; Hong Liu; Lin Sun; Youming Peng; Fuyou Liu; Manjeri A Venkatachalam; Zheng Dong
Journal:  Kidney Int       Date:  2017-09-08       Impact factor: 10.612

4.  Microvascular rarefaction and hypertension in the impaired recovery and progression of kidney disease following AKI in preexisting CKD states.

Authors:  Aaron J Polichnowski
Journal:  Am J Physiol Renal Physiol       Date:  2018-09-26

5.  Effects of chronic alcohol exposure on ischemia-reperfusion-induced acute kidney injury in mice: the role of β-arrestin 2 and glycogen synthase kinase 3.

Authors:  Lihua Wang; Yifei Zhu; Lili Wang; Jingjing Hou; Yongning Gao; Lei Shen; Jingyu Zhang
Journal:  Exp Mol Med       Date:  2017-06-23       Impact factor: 8.718

6.  Combined Blockade of Smad3 and JNK Pathways Ameliorates Progressive Fibrosis in Folic Acid Nephropathy.

Authors:  Mengjie Jiang; Jinjin Fan; Xinli Qu; Songhui Li; Susan K Nilsson; Yu Bo Yang Sun; Yaping Chen; Di Yu; Dan Liu; Bi-Cheng Liu; Mingliang Tang; Wei Chen; Yi Ren; David J Nikolic-Paterson; Xiaoyun Jiang; Jinhua Li; Xueqing Yu
Journal:  Front Pharmacol       Date:  2019-08-09       Impact factor: 5.810

Review 7.  Molecular Mechanisms of the Acute Kidney Injury to Chronic Kidney Disease Transition: An Updated View.

Authors:  Francesco Guzzi; Luigi Cirillo; Rosa Maria Roperto; Paola Romagnani; Elena Lazzeri
Journal:  Int J Mol Sci       Date:  2019-10-06       Impact factor: 5.923

8.  Chronic Kidney Disease-Associated Inflammation Increases the Risks of Acute Kidney Injury and Mortality after Cardiac Surgery.

Authors:  Angela Casas; Adrián Mallén; Arnau Blasco-Lucas; Fabrizio Sbraga; Jordi Guiteras; Núria Bolaños; Esther Castaño; Joan Torras; Josep M Cruzado; Estanislao Navarro; Miguel Hueso
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

9.  Salt-Sensitive Hypertension, Renal Injury, and Renal Vasodysfunction Associated With Dahl Salt-Sensitive Rats Are Abolished in Consomic SS.BN1 Rats.

Authors:  Jacqueline C Potter; Shannon A Whiles; Conor B Miles; Jenna B Whiles; Mark A Mitchell; Brianna E Biederman; Febronia M Dawoud; Kevin F Breuel; Geoffrey A Williamson; Maria M Picken; Aaron J Polichnowski
Journal:  J Am Heart Assoc       Date:  2021-10-23       Impact factor: 5.501

10.  Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial.

Authors:  George Bakris; Megumi Oshima; Kenneth W Mahaffey; Rajiv Agarwal; Christopher P Cannon; George Capuano; David M Charytan; Dick de Zeeuw; Robert Edwards; Tom Greene; Hiddo J L Heerspink; Adeera Levin; Bruce Neal; Richard Oh; Carol Pollock; Norman Rosenthal; David C Wheeler; Hong Zhang; Bernard Zinman; Meg J Jardine; Vlado Perkovic
Journal:  Clin J Am Soc Nephrol       Date:  2020-11-19       Impact factor: 8.237

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.